NeuroVive Pharmaceutical (Sweden) Profile

4.19
SEK 0.06  1.41%
4.0Last Month High 4.85 
4.1Trading Day  High 4.24 

NeuroVive Pharmaceutical Summary

NeuroVive Pharmaceutical AB (NVP) is traded on Stockholm Stock Exchange in Sweden. It is located in Lund, and employs 15 people. The company currently falls under 'Small-Cap' category with current market capitalization of 202.26 M. NeuroVive Pharmaceutical AB operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 50.57 M outstanding shares. NEUROVIVE PHARMA has accumulated about 46.98 M in cash with (55.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.95.
Check NeuroVive Pharmaceutical Probability Of Bankruptcy

NeuroVive Pharmaceutical Risk Profiles

Key Fundamentals

NeuroVive Pharmaceutical Against Markets

Current Ratings  

NeuroVive Pharmaceutical 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
5 
Chance of
< 75% 
NeuroVive Pharmaceutical AB engages in the research, discovery, and development of mitochondrialprotecting pharmaceuticals in Sweden and Hong Kong. more
NameNeuroVive Pharmaceutical AB
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock Stocks Directory
Business AddressLund,
ExchangeStockholm Stock Exchange
ISINSE0002575340
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.neurovive.com
Contact Number46 4 62 75 62 20
CurrencySEK - Swedish Kronor

Directors

NeuroVive Pharmaceutical Corporate Directors

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas